TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer
Robert M. Witwicki(Dana-Farber Cancer Institute), Kornélia Polyák(Dana-Farber Cancer Institute), Kimberly Stegmaier(Broad Institute), Tomáš Rejtar(Novartis (United States)), David Pellman(Broad Institute), Anne Trinh(Brigham and Women's Hospital), Gregory McAllister, Myles Brown(Harvard University), Xintao Qiu(Dana-Farber Cancer Institute), Serena J. Silver(Broad Institute), Michael D. Hogarty(Children's Hospital of Philadelphia), Muhammad B. Ekram(Brigham and Women's Hospital), Ramesh A. Shivdasani(Harvard University), Nicholas Keen, William R. Sellers(Broad Institute), Yingtian Xie(Dana-Farber Cancer Institute), Nadire Ramadan(Novartis (United States)), Rob McDonald(Novartis (United States)), Michalina Janiszewska(Scripps Research Institute), Greg Hoffman(Novartis (United States)), Henry W. Long(Dana-Farber Cancer Institute), Javad Golji(Novartis (United States)), Charles W.M. Roberts(Harvard University), David A. Ruddy(Novartis (Switzerland)), Zainab Jagani(Novartis (Switzerland)), Sosathya Sovath, Antoine de Weck(Novartis (Switzerland)), Kristine Yu(Novartis (United States)), Mijung Kwon(Harvard University), Ho Man Chan, Shaokun Shu(Peking University), Michael R. Schlabach(Q Therapeutics (United States)), Elizabeth Frias(Novartis (United States))
Cited by 78
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k